Arthur Pharma SRL
Arthur Pharma reported total assets of 93,827 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jul 2026).
The score of Arthur Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Arthur Pharma's annual accounts
| 2025 | |
|---|---|
| Net result | 58,718 € |
| Equity | 61,718 € |
| Cash | 22,927 € |
| EBITDA | 78,664 € |
| Total assets | 93,827 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jul 2026
Arthur Pharma's financial analysis
- Solvency65.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Arthur Pharma
Arthur Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1020.149.493
- VAT number
- BE1020149493
- Peppol
- Registered · 0208:1020149493 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Feb 2025
- Registered office
- 1932 Zaventem
- Latest accounts
- 2025 · filed on 29 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Arthur Pharma (SRL) has been based in Zaventem since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 58,718 € and equity of 61,718 €; its revenue is not published. Its solvency stands at 65.8%, above the median of its sector (44.2%).
Companies similar to Arthur Pharma
Companies in the same business, of comparable size and area, outside its group.
- S.G. Pharma Retail sale of pharmaceutical products Aalst · balance sheet 93,620 €
- Farmarie Retail sale of pharmaceutical products Destelbergen · balance sheet 94,659 €
- J. Veys Pharma Retail sale of pharmaceutical products Waregem · balance sheet 94,994 €
- Joeri MAX Retail sale of pharmaceutical products Peer · balance sheet 92,467 €
- OSLM Retail sale of pharmaceutical products Charleroi · balance sheet 92,150 €
- LEDA Pharma Retail sale of pharmaceutical products Bierbeek · balance sheet 91,792 €
- APVL Retail sale of pharmaceutical products Bornem · balance sheet 96,516 €
- Stelieco Retail sale of pharmaceutical products Brasschaat · balance sheet 96,802 €
Frequently asked questions about Arthur Pharma
What is the revenue of Arthur Pharma?
Arthur Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Arthur Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1020149493 for Arthur Pharma, if the company is VAT-registered. Its company number (CBE) is 1020.149.493.
Where is the registered office of Arthur Pharma?
According to the CBE register, the registered office of Arthur Pharma is in 1932 Zaventem.
What is the equity of Arthur Pharma?
At the close of the 2025 financial year, the equity of Arthur Pharma amounts to 61,718 €, a solvency of 65.8% of total assets.
Who manages Arthur Pharma?
The register lists 1 active mandates at Arthur Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Arthur Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →